Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...

A targeted molecular-imaging method under development at Rochester Institute of Technology could help detect early stages of prostate cancer and improve image-directed biopsies. RIT professor Hans ...

Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed to automate the manual process for generating prostate volume ...

Sarah Leverett, Vice President of Marketing at Clarius, highlights the time-saving potential of AI for physicians facing high demand: "95% of clinicians we recently surveyed believe AI-powered ...

To the investigator and clinician, prostate-specific antigen (PSA) level is a seemingly perfect outcome measure because it is easily assessable, quantitative, reproducible, and inexpensive. Whether ...